Temporal and spatial expression of tumor-associated antigen RCAS1 in pregnant mouse uterus.pdf
Author preprint (2.24 MB)
This is an electronic version (Author’s preprint) of the article published in American Journal of Reproductive Immunology, 2010 Feb 63(2):137-43. The original published version is available at:http://onlinelibrary.wiley.com/doi/10.1111/j.1600-0897.2009.00772.x/pdf
[en] PROBLEM: The tumor-associated antigen RCAS1 (receptor-binding cancer antigen expressed on SiSo cells) is considered to play a role in the inhibition of maternal immune response during pregnancy, and participates in the initiation of labor and placental detachment. The aim of our study was to investigate the expression of RCAS1 protein in the uteri of normal pregnant mice. METHOD: of study Uteri with fetuses were collected from pregnant ICR mice on days 1.5, 3.5, 5.5, 7.5, and 9.5 p.c., and uterine and placental tissues were obtained separately on days 11.5, 13.5, 15.5, and 17.5 p.c. Samples were examined using real-time (RT)-PCR, Western blotting, and immunohistochemical analyses. RESULTS: In normal pregnant mice, RCAS1 protein mRNA was significantly increased on day 7.5 p.c. Antigen localization was detected in the placenta, decidua, and fetus. CONCLUSION: The results of this study suggest the importance of day 7.5 p.c. for RCAS1 protein expression in connection with placentation as a possible target for future in vivo studies.
Disciplines :
Reproductive medicine (gynecology, andrology, obstetrics)
Author, co-author :
Tskitishvili, Ekaterine ; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement > Osaka University Graduate School of Medicine, Department of Obstetrics and Gynecology
Nakamura, Hitomi; Osaka University Graduate School of Medicine > Department of Obstetrics and Gynecology
Kinugasa-Taniguchi, Yukiko; Osaka University Graduate School of Medicine > Department of Obstetrics and Gynecology
Kanagawa, Takeshi; Osaka University Graduate School of Medicine > Department of Obstetrics and Gynecology
Kimura, Tadashi; Osaka University Graduate School of Medicine > Department of Obstetrics and Gynecology
Tomimatsu, Takuji; Osaka University Graduate School of Medicine > Department of Obstetrics and Gynecology
Shimoya, Koichiro; Kawasaki Medical School > Department of Obstetrics and Gynecology
Language :
English
Title :
Temporal and spatial expression of tumor-associated antigen RCAS1 in pregnant mouse uterus.
Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999, 499(180 2Pt1).
Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response-a review. Placenta 2003, 24(Suppl. A):S21-S27.
Sargent IL, Borzychowski AM, Redman C. NK cells and human pregnancy - an inflammatory view. Trends Immunol 2006, 27:399-404.
Nakashima M, Sonoda K, Watanabe T. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 1999, 5:938-942.
Tsuchiya F, Ikeda K, Tsutsumi O, Hiroi H, Momoeda M, Taketani Y, Muratasu M, Inoue S. Molecular cloning and characterization of mouse EBAG9, homolog of a human cancer associated surface antigen: expression and regulation by estrogen. Biochem Biophys Res Commun 2001, 284:2-10.
Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H, Watanabe T. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 1996, 77:1501-1509.
Ikeda K, Sato M, Tsutsumi O, Tsuchiya F, Tsuneizumi M, Emi M, Imoto I, Inazawa J, Muramatsu M, Inoue S. Promoter analysis and chromosomal mapping of human EBAG9gene. Biochem Biophys Res Commun 2000, 273:654-660.
Matsushima M, Nakashima M, Ohshima K, Abe Y, Nishimura J, Nawata H, Watanabe T, Muta K. Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells. Blood 2001, 98:313-321.
Wicherek L, Klimek M, Dutsch-Wicherek M, Kolodziejski L, Skotniczny K. The molecular changes during placental detachment. Eur J Obstet Gynecol Reprod Biol 2006, 125:171-175.
Han Y, Qin W, Huang G. Knockdown of RCAS1 expression by RNA interference recovers T cell growth and proliferation. Cancer Lett 2007, 257:182-190.
Sonoda K, Miyamoto S, Yamazaki A, Kobayashi H, Nakashima M, Mekada E, Wake N. Biologic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a pivotal regulator of tumor growth through angiogenesis in human tumor uterine cancer. Cancer 2007, 110:1979-1990.
Akahira JI, Aoki M, Suzuki T, Moriya T, Niikura H, Ito K, Okamura K, Inoue S, Sasano H, Yaegashi N. Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer. Br J Cancer 2004, 90:2197-2202.
Chatterjee M, Mohapatra S, Ionan A, Bawa G, Ali-Fehmi R, Wang X, Novak J, Ye B, Nahhas FE, Lu K, Witkin SS, Fishman D, Munkarah A, Morris R, Levin NK, Shirley NN, Tromp G, Abrams J, Draghici S, Tainsky MA. Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res 2006, 66:1181-1190.
Sonoda K, Miyamoto S, Yotsumoto F, Yagi H, Nakashima M, Watanabe K, Nakano H. Clinical significance of RCAS1 as a biomarker of ovarian cancer. Oncol Rep 2007, 17:623-628.
Giaginis C, Giagini A, Theocharis S. Receptor-binding cancer antigen expressed on SiSo cells (RCAS1): a novel biomarker in the diagnosis and prognosis of human neoplasia. Histol Histopathol 2009, 24:761-776.
Kawano K, Kaku T, Sonoda K, Hirakawa T, Kobayashi H, Ohishi Y, Nakano H. Expression of RCAS1 in female organs. Int J Gynecol Pathol 2005, 24:330-334.
Wicherek L, Popiela TJ, Galazka K, Dutch-Wicherek M, Oplawski M, Basta A, Klimek M. Metallothionein and RCAS1 expression in comparison to immunological cells activity in endometriosis, endometrial adenocarcinoma and endometrium according to menstrual cycle changes. Gynecol Oncol 2005, 99:622-630.
Wicherek L, Dutsch M, Mak P, Klimek M, Skladzien J, Dubin A. Comparative analysis of RCAS1 level in neoplasms and placenta. Acta Biochim Pol 2003, 50:1187-1194.
Ohshima K, Nakashima M, Sonoda K, Kikuchi M, Watanabe T. Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: the possible role in immune privilege. Clin Exp Immunol 2001, 123:481-486.
Wicherek L, Dutsch-Wicherek M, Mak P, Klimek M. The Role of RCAS1 and oxytocinase in immune tolerance during pregnancy. Fetal Diagn Ther 2005, 20:420-425.
Wicherek L, Klimek M, Dutsch-Wicherek M. The level of maternal immune tolerance and fetal maturity. Neuro Endocrinol Lett 2005, 26:561-566.
Wicherek L, Klimek M, Czekierdowski A, Popiela TJ, Galazka K, Tetlak T, Gilowski A, Dutsch-Wicherek M. The placental RCAS1 expression during stillbirth. Reprod Biol Endocrinol 2005, 3:24.
Tskitishvili E, Komoto Y, Kinugasa Y, Kanagawa T, Song M, Mimura K, Tomimatsu T, Kimura T, Shimoya K. Relationship between human tumor-associated antigen RCAS1 and gestational diabetes mellitus. Am J Reprod Immunol 2007, 58:440-446.
Tskitishvili E, Komoto Y, Kinugasa Y, Kanagawa T, Song M, Mimura K, Tomimatsu T, Kimura T, Shimoya K. The human tumor-associated antigen RCAS1 in pregnancies complicated by preeclampsia. J Reprod Immunol 2008, 77:100-108.
Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
Gendron RL, Baines MG. Infiltrating decidual natural killer cells are associated with spontaneous abortion in mice. Cell Immunol 1988, 113:261-267.
Baines MG, Haddad EK, Pomerantz DK, Duclos AJ. Effects of sensory stimuli on the incidence of fetal resorption in a murine model of spontaneous abortion: the presence of an alien male and postimplantation embryo survival. J Reprod Fertil 1994, 102:221-228.
Sapin V, Blanchon L, Serre AF, Lemery D, Dastuque B, Ward SJ. Use of transgenic mice model for understanding placentation: towards clinical applications in human obstetrical pathologies. Transgenic Res 2001, 10:377-398.
Ogushi T, Takahashi S, Takeuchi T, Urano T, Horie-Inoue K, Kumagai J, Kitamura T, Ouchi Y, Muramatsu M, Inoue S. Estrogen receptor-binding fragment-associated antigen 9 is a tumor-promoting and prognostic factor for renal cell carcinoma. Cancer Res 2005, 65:3700-3706.
